Drug:
Reaction: DYSPNOEA
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26532402 |
CN |
49 | 2 |
Paralysis, Pruritus, Erythema, Chills, Laryngeal oedema, Chest discomfort, Swelling, Dyspnoea, Hypersensitivity, |
||||
OXALIPLATIN, DEXTROSE MONOHYDRATE, DEXTROSE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 502 | 26532464 |
US |
68 | 1 |
Condition aggravated, Dyspnoea, Extra dose administered, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 503 | 26532486 |
EG |
39 | 2 |
Hot flush, Dyspnoea, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, BEVACIZUMAB, |
||||
| 504 | 26532591 |
US |
1 | |
Illness, Dyspnoea, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 505 | 26532622 |
EG |
59 | 2 |
Cancer fatigue, Hypophagia, Tachypnoea, Hypoalbuminaemia, General physical health deterioration, Dyspnoea, Fatigue, Febrile neutropenia, Leukopenia, Thrombocytopenia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 506 | 26532633 |
EG |
80 | 2 |
Oxygen saturation decreased, Chest discomfort, Dyspnoea at rest, Dyspnoea, Erythema, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 507 | 26532638 |
US |
||
Dyspnoea, |
||||
AMBRISENTAN, |
||||
| 508 | 26532741 |
US |
62 | 2 |
Fatigue, Asthenia, Somnolence, Hallucination, Chest pain, Dyspnoea, Dry mouth, Stomatitis, Pruritus, Dysphagia, Decreased appetite, Hot flush, Oedema peripheral, Arthralgia, Dry skin, Alopecia, Dizziness, Headache, Hypoaesthesia, Paraesthesia, Depression, Off label use, |
||||
FEDRATINIB HYDROCHLORIDE, ACYCLOVIR, ALLOPURINOL, DARBEPOETIN ALFA, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, COLCHICINE, DONEPEZIL HYDROCHLORIDE, |
||||
| 509 | 26532796 |
US |
2 | |
Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, OXYBUTYNIN CHLORIDE, FUROSEMIDE, CALCIUM, EZETIMIBE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, LANSOPRAZOLE, SILDENAFIL CITRATE, SILDENAFIL, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, GUAIFENESIN, AMBRISENTAN, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, IRON, SPIRONOLACTONE, ONDANSETRON HYDROCHLORIDE, |
||||
| 510 | 26532885 |
US |
20 | 2 |
Tachypnoea, Chills, Chest pain, Dizziness, Vision blurred, Headache, Dyspnoea, Pyrexia, Hypotension, Anaphylactic reaction, Hypoxia, Product dose omission issue, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, PENICILLIN G SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 511 | 26532973 |
EG |
63 | 2 |
Tachypnoea, Flushing, Dyspnoea, Erythema, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 512 | 26533007 |
US |
1 | |
Dyspnoea, |
||||
DAPAGLIFLOZIN, |
||||
| 513 | 26533024 |
US |
2 | |
Dyspnoea, Product use issue, |
||||
| 514 | 26533038 |
US |
62 | 1 |
Low lung compliance, Insomnia, Dyspnoea, Product substitution issue, Therapeutic response decreased, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 515 | 26533095 |
US |
38 | 2 |
Dyspnoea, Insomnia, Sneezing, Nasal congestion, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 516 | 26533295 |
US |
31 | 2 |
Dysphagia, Accidental exposure to product, Injection site haemorrhage, Chest discomfort, Dyspnoea, Pharyngeal swelling, Needle issue, Incorrect dose administered by device, |
||||
FREMANEZUMAB-VFRM, |
||||
| 517 | 26533327 |
PS |
44 | 1 |
Aplasia pure red cell, Pancytopenia, Anaemia, Fatigue, Dyspnoea, Febrile neutropenia, Asthenia, Loss of personal independence in daily activities, Dyspnoea exertional, Dizziness postural, Pallor, Conjunctival pallor, Hyperdynamic left ventricle, Normocytic anaemia, Hypochromic anaemia, Cytopenia, Pyrexia, Neutropenia, Parvovirus B19 infection, Staphylococcal bacteraemia, Neutropenic sepsis, |
||||
ANTI-THYMOCYTE GLOBULIN (RABBIT), PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, AMLODIPINE, CARVEDILOL, |
||||
| 518 | 26533391 |
US |
71 | 2 |
Influenza, Nasal congestion, Bronchitis, Dyspnoea, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 519 | 26533398 |
JP |
73 | 1 |
Cardiac failure, Renal impairment, Presyncope, Renal impairment, Flatulence, Oedema peripheral, Dehydration, Back pain, Dyspnoea exertional, Dyspnoea, Off label use, Headache, Faeces soft, Decreased appetite, |
||||
SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, MACITENTAN, MACITENTAN, MACITENTAN, MACITENTAN, MACITENTAN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, FUROSEMIDE, |
||||
| 520 | 26533450 |
EG |
49 | 2 |
Dyspnoea, Anaphylactic reaction, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), FAMOTIDINE, |
||||
| 521 | 26533500 |
US |
59 | 2 |
Chronic obstructive pulmonary disease, Nasopharyngitis, Influenza, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 522 | 26533551 |
GB |
49 | 2 |
Diverticulitis, Palpitations, Fatigue, Migraine, Hypoaesthesia, Hypoaesthesia oral, Dizziness, Pyrexia, Chills, Abdominal distension, Nausea, Diarrhoea, Dyspnoea, Wheezing, |
||||
RITLECITINIB, RITLECITINIB, RITLECITINIB, SERTRALINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 523 | 26533565 |
EU |
56 | 1 |
Dysstasia, Dyspnoea, Drug effective for unapproved indication, Off label use, |
||||
INFLIXIMAB, DURVALUMAB, DURVALUMAB, |
||||
| 524 | 26533587 |
61 | 1 | |
Angioedema, Dyspnoea, |
||||
LISINOPRIL, |
||||
| 525 | 26533674 |
79 | 1 | |
Cough, Hypertension, Tachycardia, Flushing, Dyspnoea, Dysphagia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 526 | 26533772 |
EU |
1 | |
Cardiac failure, Multiple organ dysfunction syndrome, Dyspnoea, Poisoning deliberate, Altered state of consciousness, Overdose, Labelled drug-drug interaction issue, Dry mouth, |
||||
ZOLPIDEM TARTRATE, MORPHINE, QUETIAPINE, |
||||
| 527 | 26533838 |
GB |
71 | 2 |
Cardiac flutter, Dyspnoea, |
||||
LISINOPRIL, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 528 | 26533970 |
US |
65 | 2 |
Anaphylactic reaction, Dyspnoea, Swelling, |
||||
BENZONATATE, |
||||
| 529 | 26534006 |
US |
70 | 2 |
COVID-19, Cough, Dyspnoea, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 530 | 26534101 |
US |
1 | |
Constipation, Flatulence, Abdominal pain upper, Abnormal faeces, Dyspnoea, Exercise tolerance decreased, Wheezing, Nasal inflammation, Nasal congestion, Increased viscosity of bronchial secretion, Productive cough, Steatorrhoea, Mucous stools, Gastrointestinal disorder, Sleep disorder, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, DUPILUMAB, DUPILUMAB, DORNASE ALFA, |
||||
| 531 | 26534126 |
US |
2 | |
Dyspnoea, Dyspnoea exertional, Cough, Breath sounds abnormal, Rhonchi, |
||||
| 532 | 26534225 |
GB |
38 | 2 |
Sinus headache, Pulmonary pain, Swelling of nose, Sinus pain, Headache, Constipation, Dyspnoea, |
||||
GABAPENTIN, BISOPROLOL FUMARATE, |
||||
| 533 | 26534230 |
US |
44 | 2 |
Retinal detachment, Dyspnoea, Asthma, White blood cell count decreased, Immunodeficiency, Respiratory tract congestion, Lower respiratory tract infection, Rash, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 534 | 26534281 |
US |
11 | 2 |
Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, MONTELUKAST SODIUM, MONTELUKAST, LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL TARTRATE, |
||||
| 535 | 26534343 |
US |
1 | |
Dyspnoea, |
||||
LANREOTIDE ACETATE, ACYCLOVIR, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CABERGOLINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IRON, LATANOPROST, MAGNESIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ONDANSETRON HYDROCHLORIDE, CLOPIDOGREL, LENALIDOMIDE, SERTRALINE HYDROCHLORIDE, SPIRONOLACTONE, TAMSULOSIN HYDROCHLORIDE, TORSEMIDE, |
||||
| 536 | 26534413 |
EU |
24 | 1 |
Dyspnoea, Urticaria, Sneezing, Swelling face, Pharyngeal swelling, |
||||
IOMEPROL INJECTION, |
||||
| 537 | 26534431 |
35 | 2 | |
Dyspnoea, Rash pruritic, Dizziness, |
||||
| 538 | 26534644 |
US |
74 | 2 |
Dyspnoea, |
||||
POMALIDOMIDE, |
||||
| 539 | 26534651 |
71 | 1 | |
Oxygen saturation decreased, Malaise, Dyspnoea, Hypotension, Tremor, |
||||
CETUXIMAB, |
||||
| 540 | 26534684 |
60 | 2 | |
Pneumonia, Productive cough, Respiratory failure, Dyspnoea, Inadequate diet, Hypoglycaemia, Haemoglobin decreased, Platelet count increased, |
||||
INSULIN ASPART, |
||||
| 541 | 26534692 |
CN |
79 | 2 |
Chest discomfort, Dyspnoea, Heart rate increased, Respiratory rate increased, Blood pressure decreased, Drug hypersensitivity, Discomfort, |
||||
| 542 | 26534695 |
US |
||
Infective pulmonary exacerbation of cystic fibrosis, Fatigue, Dyspnoea, Exercise tolerance decreased, Loss of personal independence in daily activities, Social problem, |
||||
DORNASE ALFA, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, OMALIZUMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, COLISTIMETHATE SODIUM, COLISTIMETHATE, FLUTICASONE PROPIONATE AND SALMETEROL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 543 | 26534705 |
US |
74 | 2 |
Dyspnoea, |
||||
LENALIDOMIDE, |
||||
| 544 | 26535087 |
US |
59 | 2 |
Seasonal allergy, Dyspnoea, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 545 | 26535091 |
US |
72 | 1 |
Dyspnoea, Drug effect less than expected, |
||||
DUPILUMAB, |
||||
| 546 | 26535163 |
US |
68 | 1 |
Dyspnoea, |
||||
UPADACITINIB, |
||||
| 547 | 26535267 |
GB |
64 | 2 |
Cardiac arrest, Multiple organ dysfunction syndrome, Myositis, Hypertransaminasaemia, Dysphagia, Myasthenia gravis, Myalgia, Dyspnoea, Aspiration, Myocarditis, Dysphonia, |
||||
PEMBROLIZUMAB, CARBOPLATIN, BISOPROLOL FUMARATE, PEMETREXED, PEMETREXED DISODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 548 | 26535382 |
|||
Myocardial infarction, Dyspnoea, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MORPHINE SULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, SIMETHICONE, SIMETHICONE 125 MG, SIMETHICONE 180 MG, SIMETHICONE CAPSULES USP, 125 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, VITAMIN E, ERGOCALCIFEROL, ERGOCALCIFEROL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), EMPAGLIFLOZIN, TICAGRELOR, PREDNISONE, SPIRONOLACTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALBUTEROL SULFATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 549 | 26535511 |
AU |
50 | 2 |
Neutropenia, Dyspnoea, Wheezing, Oropharyngeal pain, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, CELECOXIB, CICLESONIDE, CHOLESTYRAMINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FENOFIBRATE, FENOFIBRATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 550 | 26535534 |
EU |
2 | |
Dyspnoea, Oxygen saturation decreased, |
||||
OXYGEN, 0XYGEN, |
||||
| 551 | 26535587 |
US |
3 | 2 |
Metapneumovirus pneumonia, Dyspnoea, Dehydration, Pyrexia, |
||||
ELOSULFASE ALFA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, EPINEPHRINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, LIDOCAINE, METHYLPREDNISOLONE SODIUM SUCCINATE, FERROUS SULFATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 552 | 26535634 |
KR |
||
Tremor, Dyspnoea, Muscle twitching, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 553 | 26535670 |
US |
71 | 1 |
Influenza, Pneumonia, Dyspnoea, |
||||
IXAZOMIB, ACYCLOVIR, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DULOXETINE HYDROCHLORIDE, GABAPENTIN, GLIPIZIDE, GLIPIZIDE-TABLETS, MAGNESIUM OXIDE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, POMALIDOMIDE, ICOSAPENT ETHYL, DENOSUMAB, |
||||
| 554 | 26537653 |
44 | 2 | |
Anxiety, Dyspnoea, Insomnia, Urticaria, |
||||
| 555 | 26537914 |
2 | ||
Throat tightness, Laryngeal oedema, Dyspnoea, Therapy interrupted, |
||||
ICATIBANT ACETATE, LANADELUMAB-FLYO, |
||||
| 556 | 26538435 |
45 | 2 | |
Hypersensitivity, Influenza, Contraindicated product prescribed, Contraindicated product administered, Drug hypersensitivity, Burning sensation, Blood pressure increased, Fatigue, Dyspnoea, Gait inability, Immunodeficiency, Aphasia, Feeding disorder, Mast cell activation syndrome, Premature menopause, Alopecia, Muscle atrophy, Amnesia, Chronic fatigue syndrome, Fibromyalgia, Guillain-Barre syndrome, |
||||
PREDNISONE, ERGOCALCIFEROL, |
||||
| 557 | 26539355 |
30 | 2 | |
Dyspnoea, Feeling hot, Pruritus, Nausea, Hyperhidrosis, Hypoaesthesia, Hypoaesthesia, Hypoaesthesia, Swelling of eyelid, Aphasia, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ERGOCALCIFEROL, |
||||
| 558 | 26526814 |
US |
60 | 2 |
Lung neoplasm malignant, Dyspnoea, Pneumonia bacterial, Illness, |
||||
ONABOTULINUMTOXINA, |
||||
| 559 | 26526832 |
US |
61 | 2 |
Pain in extremity, Dyspnoea, Arthralgia, Headache, Pain in jaw, Inappropriate schedule of product administration, |
||||
TREPROSTINIL, TREPROSTINIL, SELEXIPAG, |
||||
| 560 | 26526851 |
US |
65 | 2 |
Blood pressure increased, Dyspnoea, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 561 | 26526899 |
US |
2 | |
Dyspnoea, Off label use, |
||||
IPRATROPIUM BROMIDE AND ALBUTEROL, IPRATROPIUM BROMIDE AND ALBUTEROL, LISINOPRIL, |
||||
| 562 | 26526937 |
US |
||
Dyspnoea, |
||||
NUSINERSEN, |
||||
| 563 | 26526990 |
US |
1 | |
Rash, Dyspnoea, |
||||
ALLOPURINOL, LENVATINIB, LENVATINIB, |
||||
| 564 | 26526993 |
US |
2 | |
Dyspnoea, Product preparation error, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 565 | 26527096 |
GB |
64 | 2 |
Jaundice, Vision blurred, Confabulation, Dyspnoea, Chest pain, Gingival bleeding, Limbal swelling, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 566 | 26527182 |
US |
||
Product use issue, Product dose omission issue, Product cleaning inadequate, Device use issue, Dyspnoea, |
||||
| 567 | 26527183 |
US |
57 | 2 |
Bronchospasm, Drug ineffective, Dyspnoea, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 568 | 26527273 |
US |
1 | |
Weight increased, Dyspnoea, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMBRISENTAN, |
||||
| 569 | 26527281 |
US |
73 | 2 |
Dyspnoea, Blood pressure fluctuation, |
||||
OXCARBAZEPINE, |
||||
| 570 | 26527282 |
US |
73 | 2 |
Dyspnoea, Insomnia, Rash, Hypertension, Drug ineffective, Product odour abnormal, Product quality issue, Product coating issue, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, OXCARBAZEPINE, |
||||
| 571 | 26527364 |
US |
79 | 1 |
Lung neoplasm malignant, Dyspnoea, Hypoacusis, Neck pain, Memory impairment, |
||||
| 572 | 26527450 |
GB |
67 | 2 |
Chest discomfort, Dyspnoea, Myopathy, Muscle spasms, |
||||
AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LANSOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 573 | 26527506 |
US |
42 | 2 |
Disease progression, Dyspnoea, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 574 | 26527629 |
BD |
74 | 1 |
Dyspnoea, Ascites, Asthenia, |
||||
ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 575 | 26527639 |
US |
77 | 2 |
Dyspnoea, |
||||
POMALIDOMIDE, |
||||
| 576 | 26527649 |
US |
33 | 1 |
Agonal respiration, Dyspnoea, Asthenia, Chest pain, Nasopharyngitis, Headache, |
||||
DUPILUMAB, |
||||
| 577 | 26527879 |
CA |
70 | |
Wheezing, Body temperature increased, Cataract, Body temperature decreased, Atrioventricular block, Chest pain, Chills, Coronary artery occlusion, Dyspnoea, Dyspnoea exertional, Exercise tolerance decreased, Fall, Foot deformity, Forced expiratory volume decreased, General physical health deterioration, Hyperhidrosis, Hypoventilation, Limb injury, Malaise, Musculoskeletal chest pain, Obstructive airways disorder, Pain in extremity, Skin cancer, Sneezing, Stress, Throat irritation, Total lung capacity decreased, Tremor, Weight decreased, Myocardial infarction, Pneumonia, Cough, Fatigue, Lower respiratory tract infection, Viral infection, Incorrect dose administered, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MEPOLIZUMAB, |
||||
| 578 | 26527984 |
GB |
67 | 2 |
Chest discomfort, Myopathy, Muscle spasms, Dyspnoea, |
||||
AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LANSOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 579 | 26528076 |
US |
1 | |
Device malfunction, Dyspnoea, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 580 | 26528089 |
US |
2 | |
Dyspnoea, Product dose omission issue, Overdose, Incorrect dose administered by product, Device malfunction, Drug ineffective, Intentional overdose, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 581 | 26528219 |
US |
||
Palpitations, Asthenia, Dizziness, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, |
||||
| 582 | 26528226 |
MX |
64 | 1 |
Chylothorax, Pericardial effusion, Drug resistance, Pleural effusion, Dyspnoea, |
||||
IMATINIB, DASATINIB, |
||||
| 583 | 26528287 |
US |
78 | 2 |
Dyspnoea, Nausea, Flushing, |
||||
VITAMIN C, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, EVOLOCUMAB, FERRIC DERISOMALTOSE, |
||||
| 584 | 26528428 |
CN |
72 | 2 |
Dyspnoea, Asthma, Wrong technique in product usage process, Product dose omission issue, Oxygen saturation decreased, Device delivery system issue, Taste disorder, |
||||
| 585 | 26528542 |
IQ |
51 | 2 |
Rash, Hypersensitivity, Dyspnoea, |
||||
| 586 | 26528575 |
US |
1 | |
Atypical pneumonia, Dyspnoea, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 587 | 26528619 |
CA |
78 | 2 |
Pericarditis, Hyponatraemia, Inappropriate antidiuretic hormone secretion, Dyspnoea, |
||||
OXCARBAZEPINE, |
||||
| 588 | 26528685 |
US |
67 | 1 |
Anti-neutrophil cytoplasmic antibody positive vasculitis, Cryptococcosis, Acute febrile neutrophilic dermatosis, Dyspnoea, Haemoptysis, Pneumonia, Blister, Purpura, Face oedema, Pyrexia, Metabolic encephalopathy, Sepsis, Acute respiratory failure, |
||||
HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE, NIFEDIPINE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PREDNISONE, ACYCLOVIR, |
||||
| 589 | 26528842 |
AU |
5 | 2 |
Respiratory distress, Oropharyngeal discomfort, Dyspnoea, Dyspnoea, Chest discomfort, Infusion related reaction, |
||||
HUMAN IMMUNOGLOBULIN G, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 590 | 26528895 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Malaise, Pain, Oedema, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
| 591 | 26528896 |
US |
64 | 2 |
Chest pain, Dyspnoea, Cough, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 592 | 26528909 |
EU |
1 | |
Drug ineffective, Oxygen saturation decreased, Infection, Dyspnoea, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, TIOTROPIUM BROMIDE INHALATION SPRAY, MONTELUKAST, MONTELUKAST, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ATOMOXETINE HYDROCHLORIDE, |
||||
| 593 | 26528934 |
EU |
73 | 2 |
Syncope, Diarrhoea, Oedema peripheral, Increased viscosity of upper respiratory secretion, Gait disturbance, Dry skin, Faeces discoloured, Arthralgia, Dry mouth, Abdominal distension, Nasopharyngitis, Head injury, Epistaxis, Malaise, Loss of consciousness, Dry throat, Nasal dryness, Dyspnoea, Ear dryness, Scleroderma, Lip haemorrhage, Fall, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, BOSENTAN, AMLODIPINE BESYLATE, HYDROXYCHLOROQUINE SULFATE, FUROSEMIDE, MAGNESIUM, |
||||
| 594 | 26528937 |
EU |
74 | 2 |
Agonal respiration, Dyspnoea, Loss of consciousness, |
||||
IOMEPROL INJECTION, |
||||
| 595 | 26528958 |
84 | 2 | |
Malaise, Productive cough, Wheezing, Dyspnoea, Therapy interrupted, Dehydration, Respiratory syncytial virus test positive, Hypoxia, Oedema peripheral, Pneumonia viral, Pneumonia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 596 | 26529033 |
JP |
4 | |
Nasopharyngitis, Headache, Nausea, Feeling abnormal, Dyspnoea, Diarrhoea, |
||||
ZILUCOPLAN, |
||||
| 597 | 26529128 |
CA |
43 | 2 |
Condition aggravated, Drug ineffective, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Joint range of motion decreased, Joint swelling, Lip dry, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 598 | 26529184 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, RISEDRONATE SODIUM, RITUXIMAB, CALCIUM CARBONATE, ANTACID, BECLOMETHASONE DIPROPIONATE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CLONAZEPAM, ROSUVASTATIN, ERGOCALCIFEROL, PREDNISONE, TRAMADOL HYDROCHLORIDE, |
||||
| 599 | 26529191 |
GB |
24 | 1 |
Dyspnoea, Rash maculo-papular, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 600 | 26529271 |
CA |
56 | 1 |
Anaphylactic reaction, Urticaria, Chills, Nausea, Vomiting, Dyspnoea, Throat tightness, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28